- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Comparing Apples to Broccoli
Pharmaceutical Executive
In late March, the Supreme Court debated the merits-or lack thereof-of the Obama Administration's Patient Protection and Affordable Care Act. Can you match the analogy with the Justice?
In late March, the Supreme Court debated the merits—or lack thereof—of the Obama Administration's Patient Protection and Affordable Care Act (ACA). The law's key provision, the individual mandate, sparked a proliferation of analogies from the Justices. Some of the analogies were helpful, some less so, but each one provided an insight into that particular Justice's thinking on the issue. Can you match the analogy with the Justice? (Hint: Two are from Justice Scalia)
Photo: Chip Somodevilla/Getty Images
Answers: A: Justice Scalia. B: Justice Breyer. C: Justice Sotomayor. D: Chief Justice Roberts. E: Justice Scalia.
What Every Pharma CEO Should Know About Unlocking the Potential of Scientific Data
December 11th 2024When integrated into pharmaceutical enterprises, scientific data has the potential to drive organizational growth and innovation. Mikael Hagstroem, CEO at leading laboratory informatics provider LabVantage Solutions, discusses how technology partners add significant value to pharmaceutical R&D, in addition to manufacturing quality.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
